Investing.com - Atossa Genetics (NASDAQ:ATOS) reported on Monday third quarter earnings that missed analysts' forecasts and revenue that was in line with expectations.
Atossa Genetics announced earnings per share of $-0.060 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.050 on revenue of $0.00.
Atossa Genetics shares are down 5.02% from the beginning of the year, still down 69.73% from its 52 week high of $2.82 set on November 8, 2021.
Atossa Genetics follows other major Healthcare sector earnings this month
Atossa Genetics's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar